ElectriPlast: "V" is for Valentine or Validation...

Anticipation

of a Thing is

Half the Fun




By PK
ElectriPlast Blog Publisher



[ ElectriPlast Blog (EB) Publisher's Note(s): There is substance to this message, to reinforce it though, I would like to share a recent interaction had with one of your fellow EB Readers on 12 Feb 2007.

Supplemental Note for those interested -- the Domino's have begun to fall. According to varied sources, this is merely one of the numerous announcements slated to appear over the coming months. ]


Hi PK:

I was ecstatic to see that ElectriPlast was actually licensed for an actual product or products. I'm wondering what product and in what division the ElectriPlast will be used. Hopefully this will occur in all 3 divisions and in a few different products. Knowles is a solid company and, as I'm sure you are aware, a giant in their field. This is positive, positive news and I was very excited to see this at 6:30 am PST this morning.

In my business, audio recording and performing, we uses Knowles almost 100% for live performance monitoring. U2, Rolling Stones, McCartney and as I said almost everyone uses their In-Ears monitors for live performances all over the world. They are also huge in mini microphones as well as dozens upon dozens of other products including, of course, hearing aids. I'm sure you're waaay ahead of me.

This is a happy day and I think that more than anything it is the beginning of validation to the rest of the world that ElectriPlast will actually be used in real products by a real corporation. This doesn't appear to be a "let's license the product, do many, many months worth of testing, and see what we can use this stuff for".

This is good, however, my opinion is, is that ITKG needs a real press release writer/publicist to help them to make the most of these press releases. They're a little short on fanfare and trumpeting their accomplishments. Everyone wants to be with a winner and around some excitement. For me, this is a big day for this company...

Hope you're well and best wishes to you.

EB Reader, CA



First a Press Release from the Bellingham Herald, 13 Feb 2007:


Breakthrough sale for Integral Technologies

By The Bellingham Herald, 13 Feb 2007

Bellingham-based Integral Technologies has received its first commercial order for a product it has spent years developing.

Knowles Electronics, a major provider of microphones and receivers for the hearing aid industry, will begin using Integral’s proprietary ElectriPlast technology in its products.

Electri Plast is a highly conductive resin-based polymer that can be molded into virtually any shape. The product has the potential to be used in a variety of applications, including antennas, shielding, lighting, circuitry and medical devices, according to the company press release.

Details about the order’s size were not disclosed. Bill Robinson, CEO of the company, said he expects this order to lead to others, and there is the potential that this technology could be used in thousands of Knowles Electronics products.

For more information about Integral Technologies, visit http://www.itkg.net/

Second, with permission of ChangeWave, an exerpt from their latest release 13 Feb 2007:

Extreme Portfolio Integral Technologies [ OTCBB: ITKG ]

By ChangeWave

It's So Commercial

Yesterday, the more speculatively inclined Integral Technology (ITKG) announced its first commercial order. Knowles Electronics -- a provider of microphones and receivers to the hearing health industry -- entered into a licensing agreement with Integral and purchased ITKG's proprietary ElectriPlast technology for use in their products.

Knowles Electronics entered into a licensing agreement with Integral and has purchased its proprietary ElectriPlast technology for use in Knowles' products.

Knowles is a big "playa" in microphones and receivers for the hearing health industry -- they are credited with the miniaturization of the acoustic transducer, which has enabled the design and manufacture of smaller hearing aids.

This deal is emblematic of how Integral is doing business today -- not six months ago. We're told by those who know this deal that from non-disclosure agreement (NDA) to proposal to sample to license -- took six weeks, that's it!

Other deals like this have taken six months or longer. So what's the difference today?

Integral has the Jasper Rubber organization to manufacture and deliver the ElectriPlast pellets immediately and in exact formulations.

Integral now has the capability to rapidly take ElectriPlast in any of its more than 120 patented and patent-pending forms to thousands of companies like Knowles.

Knowles is part of Dover Corp. ($6 billion dollars in annualized sales), which brings us to the second reason why this kind of deal is so important to ITKG.

What we are seeing is the classic Trojan Horse scenario. The little subsidiary who tries ElectriPlast and then tells another bigger division, who tells another and another and, bam! -- hundreds of thousands dollars in royalty revenues turn into millions of dollars.

That's what is so important about the Knowles deal. The lag time between NDA and signed deals has now been cut by up to 90%.

Every major deal is worth about an extra 50 cents per share in valuation -- and Integral is sitting on at least 100 more deals.

Do the math and then take advantage of the dips to accumulate ITKG if you haven't already done so.

ElectriPlast: Fulfilling Market Orders...

Attaining

First of many

IP Product

Orders


By © 2006 BusinessWire
February 12, 2007 9:00 AM ET


Integral Technologies Receives First Commercial Order For ElectriPlast™ from Knowles Electronics

Integral Technologies, Inc. ITKG ("Integral"), announces that Knowles Electronics, LLC. ("Knowles") (www.knowleselectronics.com) has entered into a licensing agreement with Integral and has purchased the Company's proprietary ElectriPlast™ technology for use in their products.

Knowles is the world's leading provider of microphones and receivers to the hearing health industry. They are credited with the miniaturization of the acoustic transducer, which has enabled the design and manufacture of smaller hearing aids. Knowles has increased the transducers' sensitivity and maximum output, helping those with even the most profound hearing loss.

This order and shipment represents the first commercial order for Integral's ElectriPlast™ technology. Integral's manufacturing agreement with Jasper Rubber provides for faster delivery of the multiple ElectriPlast™ applications.

Knowles continues its innovations today through:

1. pioneering techniques in vibration feedback reduction
2. improved directionality through superior microphone matching techniques
3. aiding OEM customers' design efforts by offering digital transducers

Knowles is making the designs of today a reality and is constantly pushing the limits of technology for tomorrow's products.

ElectriPlast™, the world's first highly conductive polymer, was recently selected as a recipient of the Consumer Electronic Show's Innovations 2007 Design and Engineering Award in the Enabling Technologies product category.

Integral Technologies continues to work with numerous companies that are exploring over 111 patented and patent pending identified applications of the Company's ElectriPlast™ technology.


Integral Technologies

Integral Technologies, Inc. (www.itkg.net) is the developer of an innovative electrically conductive resin-based material called "ElectriPlast™," a highly conductive recipe that can be molded into virtually any shape or dimension associated with the range of plastics, rubbers and other polymers. Our IP consists of ElectriPlast™ and thousands of different applications pertinent to a wide variety of industries. To date, we have had 24 US patents issued, or allowed and pending issuance, and 87 patents pending on ElectriPlast™ applications. Various examples of industries where ElectriPlast™ can be used are antennas, shielding, lighting, circuitry, switch actuators, resistors, and medical devices, to name just a few. The company is currently introducing these new products and ElectriPlast™ technology on a global scale.

This press release contains "forward-looking statements" within the meaning of Section 27A of the 1933 Securities Act and Section 21E of the 1934 Securities Exchange Act. Actual results could differ materially, as the result of such factors as (1) competition in the markets for the products and services sold by the company, (2) the ability of the company to execute its plans, and (3) other factors detailed in the company's public filings with the SEC. By making these forward-looking statements, the Company can give no assurances that the transaction described in this press release will be successfully completed, and undertakes no obligation to update these statements for revisions or changes after the date of this release.

For more detailed information on the company and the technologies described above please visit our web site at www.itkg.net or contact Shareholder Relations at 888-666-8833 or The Investor Relations Group, at 212-825-3210. To review the company's filings with the SEC, please go to www.sec.gov. Contact Information: Integral Tech. Michael Pound, 888-666-8833

ElectriPlast: Let’s Hear it for Hippocrates!

Still Disruptive

After All

These Years



By Vince S.
ElectriPlast Blog Editor



Father of Modern Medicine

The Greek physician, Hippocrates, 460-377 BCE, is generally acknowledged as the father of medicine. So pervasive was his reputation that, twenty-four centuries after he saw his last patient, the medical profession still honors him by administering his eponymous oath to new physicians. After many translations from ancient Greek to Latin and the European languages, including three iterations of English, the Hippocratic Oath has come to mean first, do no harm. Although there is controversy as to whether Hippocrates actually said those words, his enduring philosophy becomes even more prophetic as technology moves the science of medicine forward, while ensuring physician and patient alike of quality results.

Given the genesis of Integral Technologies, which initially focused on antenna systems, the medical technology field has been little more than a speck on the radar of most who follow this company. Not so for a recent visitor to the Consumer Electronics Show, a physician who appears to be visionary for his insight regarding the application of new technology to medicine. In fact, the inspiration for this article resulted from perusing his website and contemplating the role ElectriPlast might play as a biomaterial in the field of medical technology.


Enter ElectriPlast

Electrosurgical tools such as graspers, scissors, hooks and probes are routinely used in laparoscopic as well as open surgical procedures. Precision made and finely balanced, electrosurgical tools are typically made of metal with an insulating cover. With them, the surgeon cuts, cauterizes and coagulates tissue using radio-frequency electrical energy. However, over time, metal tools become problematic as the insulation wears down, putting the patient at risk of receiving internal burns. Also, since metal core instruments are relatively heavy, there is the risk that physician hand fatigue could lead to imprecise movements and inadvertent cuts. (Remember the Hippocratic Oath: First, do no harm.)

Metal core tools also present other challenges in terms of their physical characteristics, shape and durability. So, here is the bottom line. Metal core electrosurgical instruments, cabling, housing and motor components for the generator are candidates for ElectriPlast. Our IP should exceed the standards of the current equipment by combining conductivity (RF electrical energy) with the strength of titanium instruments, while combining lasting insulating capabilities with malleability and durability.


Innovation: the Only Constant

According to Medical Device and Diagnostic Industry, a medical device magazine,

“medical device designers are increasingly driven by the same trends that influence the consumer product designers.”

Given that innovation is the only constant in the consumer products world, there is every reason to expect that our disruptive intellectual property, ElectriPlast, will catch on in the medical device design studios. One Integral patent, low cost electrical stimulation and shock devices manufactured from conductive loaded resin-based materials, has enormous potential in this sector. (It also has potential as a stun gun, cattle prod and security crowd control device. Remember, each patent has numerous applications!)

Over a year ago, a manufacturer of pacemakers, defibrillators and similar cardiovascular devices contacted Integral. They wanted to know if a certain plastic they use in their product line had been tested with ElectriPlast. The answer was affirmative, and we gave them the specifications. As a result, that company initiated research and development testing using our IP, but not before signing the obligatory nondisclosure agreement. Two huge factors drive the potential of the cardiovascular market: Aging and obesity, both growing health concerns in the United States. As a result, the medical industry sees many opportunities at the intersection of biomaterials and new technology. Integral will surely be there.


ElectriPlast: the New Biomaterial?

Just so you know, there are over 60 leading players in the field of cardiovascular devices (pacemakers, defibrillators and stents) worldwide. And who might some of them be? For a start, try Abbott, Boston Scientific, Johnson and Johnson, Medtronic and St. Jude Medical among others. All small fry, huh?

But there are others knocking at Integral’s door. For instance, a blood transfusion device manufacturer asked if ElectriPlast could improve their product. After much discussion, it was agreed that ElectriPlast would make their device more efficacious than the model they had on the market. Bingo, another NDA!

According to several credible sources, over 100 companies are working under NDA arrangements with Integral Technologies to incorporate ElectriPlast into their research and development strategies. It is an article of faith that once an entity reaches the R&D phase, it is a foregone conclusion that they have already planned to move to the license agreement phase. And by definition, companies who sign license agreements anticipate production. Looks like those medical device design studios will be working overtime.


And What About Hippocrates?

How would Hippocrates be evaluated, if he were alive today? Well, let’s look at his record. Basically, his medical practice was very different from that of his colleagues. His contemporaries diagnosed illness based on superstition, evil spirits and capricious gods. Not Hippocrates. He based his diagnoses on observations and on his studies of the human body. Other physicians and intellectuals believed thoughts, ideas and feelings came from the heart. Not Hippocrates. He argued that the brain, not the heart, was the center for such activities. He was the first physician to accurately describe the symptoms of pneumonia, as well as epilepsy in children. And among his many other innovative and disruptive ideas, he believed in the natural healing process of rest, good diet, fresh air and cleanliness. Sounds like an innovative and disruptive kind of guy to me.

In fact, I’m nominating him as an honorary member of the Integral Technologies Board of Directors! After all, what else would you expect from a physician who was "Hip" centuries before it became popular.